BioE, Inc. (Formally known as BioErgonomics) And M. D. Anderson Cancer Center Form Research Partnership To Evaluate Cord Blood Stem Cell's Ability To Help Treat Cancer  
1/29/2007 12:44:57 PM

ST. PAUL, Minn. & AUSTIN, Texas--(BUSINESS WIRE)--BioE®, Inc., a biomedical company that provides enabling, high-quality cellular tools for drug discovery and therapeutic research, and The University of Texas M. D. Anderson Cancer Center announced today a research partnership to evaluate the potential of BioE’s cord blood stem cell — the Multi-Lineage Progenitor Cell™ (MLPC™) — to help treat cancer.